共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R032001-5mg | 5mg | 现货 |
3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-... MSC2156119 |
99% |
|
|
阿拉丁 | E126424-5mg | 5mg | 现货 |
特泊替尼 EMD 1214063 |
Moligand™, ≥98% |
|
|
阿拉丁 | E126424-10mg | 10mg | 现货 |
特泊替尼 EMD 1214063 |
Moligand™, ≥98% |
|
|
阿拉丁 | E126424-50mg | 50mg | 现货 |
特泊替尼 EMD 1214063 |
Moligand™, ≥98% |
|
|
阿拉丁 | E126424-100mg | 100mg | 现货 |
特泊替尼 EMD 1214063 |
Moligand™, ≥98% |
|
|
阿拉丁 | E126424-25mg | 25mg | 现货 |
特泊替尼 EMD 1214063 |
Moligand™, ≥98% |
|
|
阿拉丁 | E420583-1ml | 1ml | 现货 |
特泊替尼 EMD 1214063 |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ003AL3-50mg | 50mg | 现货 |
3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-... 3-[1,6-Dihydro-1-[[3-[5-[(1-... |
98% |
|
|
凯为 | JZ003AL3-100mg | 100mg | 现货 |
3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-... 3-[1,6-Dihydro-1-[[3-[5-[(1-... |
98% |
|
|
凯为 | JZ003AL3-250mg | 250mg | 现货 |
3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-... 3-[1,6-Dihydro-1-[[3-[5-[(1-... |
98% |
|
|
凯为 | JZ003AL3-500mg | 500mg | 现货 |
3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-... 3-[1,6-Dihydro-1-[[3-[5-[(1-... |
98% |
|
|
凯为 | JZ003AL3-1g | 1g | 现货 |
3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-... 3-[1,6-Dihydro-1-[[3-[5-[(1-... |
98% |
|
|
毕得 | BD305474-5mg | 5mg | 现货 |
3-(1-(3-(5-((1-甲基哌啶-4-基)甲氧基)... 3-(1-(3-(5-((1-Methylpiperid... |
98% |
|
|
毕得 | BD305474-50mg | 50mg | 现货 |
3-(1-(3-(5-((1-甲基哌啶-4-基)甲氧基)... 3-(1-(3-(5-((1-Methylpiperid... |
98% |
|
|
毕得 | BD305474-100mg | 100mg | 现货 |
3-(1-(3-(5-((1-甲基哌啶-4-基)甲氧基)... 3-(1-(3-(5-((1-Methylpiperid... |
98% |
|
|
毕得 | BD305474-250mg | 250mg | 现货 |
3-(1-(3-(5-((1-甲基哌啶-4-基)甲氧基)... 3-(1-(3-(5-((1-Methylpiperid... |
98% |
|
|
毕得 | BD305474-1g | 1g | 现货 |
3-(1-(3-(5-((1-甲基哌啶-4-基)甲氧基)... 3-(1-(3-(5-((1-Methylpiperid... |
98% |
|
|
百灵威 | JK9000029-5MG | 5MG | 35天 |
特泊替尼 Tepotinib, 98% |
98% |
|
|
百灵威 | JK9000029-10MG | 10MG | 35天 |
特泊替尼 Tepotinib, 98% |
98% |
|
|
百灵威 | JK9000029-25MG | 25MG | 35天 |
特泊替尼 Tepotinib, 98% |
98% |
|
|
百灵威 | JK9000029-100MG | 100MG | 35天 |
特泊替尼 Tepotinib, 98% |
98% |
|
|
源叶 | S80093-5mg | 5mg | 现货 |
EMD 1214063 EMD 1214063 |
99% |
|
|
源叶 | S80093-10mg | 10mg | 现货 |
EMD 1214063 EMD 1214063 |
99% |
|
|
源叶 | S80093-25mg | 25mg | 现货 |
EMD 1214063 EMD 1214063 |
99% |
|
|
源叶 | S80093-100mg | 100mg | 期货,请咨询 |
EMD 1214063 EMD 1214063 |
99% |
|
|
源叶 | T93068-1ml | 1ml | 期货,请咨询 |
特泊替尼 EMD 1214063 |
10mM in DMSO |
|
|
Target Mol | T6121-1mg | 1mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-2mg | 2mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-5mg | 5mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-10mg | 10mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-25mg | 25mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-50mg | 50mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-100mg | 100mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Target Mol | T6121-500mg | 500mg | 现货 |
特泊替尼 Tepotini |
99.81% |
|
|
Am | A242274-50mg | 50mg | 现货 |
Tepotinib Tepotini |
98% |
|
|
Am | A242274-5mg | 5mg | 现货 |
Tepotinib Tepotini |
98% |
|
|
Am | A242274-10mg | 10mg | 现货 |
Tepotinib Tepotini |
98% |
|
|
Am | A242274-100mg | 100mg | 现货 |
Tepotinib Tepotini |
98% |
|
|
Am | A242274-1mg | 1mg | 现货 |
Tepotinib Tepotini |
98% |
|
|
MCE | HY-14721-100mg | 100mg | 现货 |
Tepotinib Tepotini |
99.87% |
|
|
MCE | HY-14721-50mg | 50mg | 现货 |
Tepotinib Tepotini |
99.87% |
|
|
MCE | HY-14721-10mg | 10mg | 现货 |
Tepotinib Tepotini |
99.87% |
|
|
MCE | HY-14721-10mM*1mL | 10mM*1mL | 现货 |
Tepotinib Tepotini |
99.87% |
|
|
MCE | HY-14721-5mg | 5mg | 现货 |
Tepotinib Tepotini |
99.87% |
|
|